NASDAQ$NKTX

Nkarta Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Nkarta reported Q4 2024, net loss of $25.9M, diluted EPS of $-0.35.

For Q4 2024, Nkarta reported a net loss of $25.9M, diluted EPS was $-0.35. Management discussed operating trends, liquidity, and outlook in the linked filing.

  • Net loss $25.9M.
  • Diluted EPS $-0.35.
  • Nkarta highlights segment execution and capital priorities.

Headline financials

Total Revenue

$0.00

Previous: $10.5M-100.0%
EPS (adj)

-$0.35

Previous: -$0.57+38.6%
R&D Expenses

$96.7M

Previous: $96.8M-0.0%
G&A Expenses

$31.5M

Previous: $34.9M-9.8%
Net Loss Per Share (Basic & Diluted)

-$1.60

Previous: -$2.40+33.3%
Total Operating Expenses

$128M

Previous: $132M-2.6%
Interest Income

$19.3M

Previous: $14.1M+36.9%
Other Income, Net

$87K

Previous: $42K+107.1%
Total Other Income, Net

$19.4M

Previous: $14.1M+37.1%
Weighted Average Shares Outstanding

67.9M

Previous: 49.0M+38.5%
Net Income

-$25.9M

Previous: -$27.8M+6.7%
Operating Income

-$128M

Previous: -$31.2M-311.1%

Revenue & EPS history

Nkarta · Revenue · Quarterly

$0

Q4 2024-100%vs Q4 2023

Forward guidance

The filing discusses Nkarta's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.

Tailwinds

  • Clinical milestones and cash runway extend development timelines.
  • Nkarta discussed operating priorities and capital allocation for upcoming periods.
  • Liquidity and balance-sheet capacity support ongoing operations.

Headwinds

  • GAAP profitability remained under pressure in Q4 2024.
  • Macro, input costs, and FX may pressure margins quarter to quarter.
  • Segment mix and one-time items can affect year-over-year comparability.
  • R&D spend and trial outcomes drive near-term losses.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.9%

Avg return

Earnings day

-2.2%

Avg return

5 days after

-0.9%

Avg return

30 days after

63%

15 / 24 earnings

Positive

+16.2%

Q4 2021

Best reaction

-30.3%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+0.9%-14.8%
Q1 2026+3.5%-16.1%-13.2%
Q3 2025+3.1%-4.6%-4.6%
Q2 2025+12.8%+19.9%+0.5%
Q1 2025+1.2%-0.6%-4.6%
Q4 2024+3.2%-15.4%+13.3%
Q3 2024-4.8%-9.0%-23.0%
Q2 2024+1.2%+0.0%+10.3%
Q1 2024-2.3%+2.3%+3.1%
Q4 2023-30.3%-22.8%-43.0%
Q3 2023-5.6%+7.0%+27.0%
Q2 2023-0.5%-1.0%-20.5%
Q1 2023-4.1%-4.1%-0.9%
Q4 2022+1.3%-7.1%+19.3%
Q3 2022-8.4%-2.1%-35.5%
Q2 2022+8.8%+11.1%-8.5%
Q1 2022+12.8%+11.1%+6.9%
Q4 2021+16.2%+6.2%-15.2%
Q3 2021+7.7%+7.2%-15.0%
Q2 2021-1.9%-5.0%-29.0%
Q4 2020+0.0%-14.4%-30.3%
Q3 2020+2.9%+14.5%+122.0%
Q2 2020-7.0%-12.0%+21.1%
Q1 2021+11.3%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro